Material Assets Material AssetsMaterial Assets … · ABS, a colour masterbatch was added: a pure...

MATERIALS

Three key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home

healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices, for which OEMs require non-industrial, aesthetically-appealing equipment. This demands materials that meet functional,

aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved in home healthcare.

These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.

Trinseo’s Magnum ABS resins use continuous mass polymerisation technology. This article discusses the main benefits of mass polymerisation over emulsion process technology here, followed by an overview of multiple performance tests, and findings that validate suitability for a healthcare environment.

With mass ABS different ingredients are added throughout a continuous process. Mass polymerisation cascades a series of reactors resulting in several chemical processes, specifically tuned for optimal rubber grafting and particle sizing. The process begins with a solution of uncrosslinked rubber dissolved in a mixture of monomers and solvent(s). At the end, the residual monomer and solvent is removed, leaving highly pure ABS.

Material Assets

Ben Porter, Trinseo, explains how the

company is meeting medical requirements

with its resins

In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the resin and the final product is more yellow.

Putting Magnum 8391 MED to the test

Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.

Magnum 8391 MED was compared with established, better-known, emulsion ABS resins.

TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, white base colour.

For aesthetic reasons, mass ABS is preferred because its whiter base colour is easier to self-colour, especially for light colours used in medical applications. It appears ‘cleaner’ and more visually appealing.

Figure 2: Natural resins manufactured through eABS versus mABS

Tests also measured colour differences based on the CIE LAB colour system which measures colour along three axes.

Figure 3: The CieLAB colour system

Figure 1: Emulsion vs. Mass ABS Production Process

moulded applications in the home health device market.moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on

tests show that Magnum suits a range of medical applications

moulding performance at different conditions; UV stability in

stringent material specifications. However, several Trinseo

With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent,

aesthetically-appealing equipment. This

medical requirements with the Magnum ABS resins,

in water through a batch process. This requires high levels

polymer. The latex is then coagulated, producing an ABS

to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due

medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved demonstrating the potential benefits for customers involved in home healthcare. demonstrating the potential benefits for customers involved

explains how the explains how the Ben Porter, Trinseo,

explains how the Ben Porter, Trinseo,

medical requirements

aesthetically-appealing equipment. This demands materials that meet functional,

aesthetic, performance and haptic requirements. Therefore,


the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant

polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded

in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS

company is meeting

Material AssetsMaterial AssetsMaterial Assets


demand for home healthcare devices, demand for home healthcare devices, company is meeting

demand for home healthcare devices, for which OEMs require non-industrial, aesthetically-appealing equipment. This with its resins

In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS

In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels


tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices

With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.

TEST ONE: BASE COLOUR COMPARISON

Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.


moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.

These resins were designed for automotive applications,

Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in

tests show that Magnum suits a range of medical applications tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications

(diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.

stringent material specifications. However, several Trinseo

such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare

Magnum 8391 MED, making it Trinseo’s offering for injection

These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications,

8391 MED for medical applications, specifically: Base colour

stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo

such as housings for inhalers (asthma sprays), injection devices

aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins,

indoor exposure and residual volatiles levels.

Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-

These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting Magnum 8391 MED was compared with established, better-

known, emulsion ABS resins. known, emulsion ABS resins. known, emulsion ABS resins.

TEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISON

devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on

With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due

a continuous process yields a resin with a highly consistent, Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.

With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent,

With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,

With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISON

These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting


These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting

demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved

aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved demonstrating the potential benefits for customers involved demonstrating the potential benefits for customers involved in home healthcare.

medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved

Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved

aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved

aesthetic, performance and haptic requirements. Therefore, aesthetic, performance and haptic requirements. Therefore,

with its resins

Trinseo’s TS&D team is showing its capabilities in meeting

demands materials that meet functional, aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting Trinseo’s TS&D team is showing its capabilities in meeting Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, Trinseo’s TS&D team is showing its capabilities in meeting Trinseo’s TS&D team is showing its capabilities in meeting

Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-known, emulsion ABS resins. known, emulsion ABS resins. Magnum 8391 MED was compared with established, better-known, emulsion ABS resins. known, emulsion ABS resins. Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-known, emulsion ABS resins.


Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-known, emulsion ABS resins.


Magnum 8391 MED was compared with established, better-known, emulsion ABS resins.

TEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISON

devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection

(diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.

Magnum 8391 MED was compared with established, better-known, emulsion ABS resins. known, emulsion ABS resins.

Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.

devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.

devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.

devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection

Magnum 8391 MED was compared with established, better-known, emulsion ABS resins. known, emulsion ABS resins.

moulded applications in the home health device market.moulded applications in the home health device market.

devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.


medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved

These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications,

moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.

These resins were designed for automotive applications, These resins were designed for automotive applications,


Magnum 8391 MED was compared with established, better-

These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo

Magnum 8391 MED was compared with established, better-stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications

These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications

suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications

(diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on

such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare

tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare

tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare

tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices



These resins were designed for automotive applications, These resins were designed for automotive applications, These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting


stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices

stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications tests show that Magnum suits a range of medical applications tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices


stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications

to higher polymer processing aid loading. ABS produced in Magnum 8391 MED, making it Trinseo’s offering for injection

With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,


a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent,

With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,



tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare


With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, Magnum 8391 MED, making it Trinseo’s offering for injection a continuous process yields a resin with a highly consistent,

With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,

With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due (diabetes), hand-held monitoring and other home healthcare

devices. Therefore, Trinseo obtained biocompatibility on

such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on

such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare

TEST ONE: BASE COLOUR COMPARISONsuch as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on

such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on

With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in devices. Therefore, Trinseo obtained biocompatibility on

Magnum 8391 MED, making it Trinseo’s offering for injection

TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due

These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications



stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo

TEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due


in home healthcare.


medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved in home healthcare. demonstrating the potential benefits for customers involved in home healthcare.


in home healthcare. demonstrating the potential benefits for customers involved in home healthcare.


stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo known, emulsion ABS resins. known, emulsion ABS resins. known, emulsion ABS resins. known, emulsion ABS resins. stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications such as housings for inhalers (asthma sprays), injection devices

stringent material specifications. However, several Trinseo known, emulsion ABS resins. known, emulsion ABS resins. stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo known, emulsion ABS resins.

TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONWith emulsion ABS the end product has a yellower colour due TEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISONTEST ONE: BASE COLOUR COMPARISON

These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting

tests show that Magnum suits a range of medical applications

suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo tests show that Magnum suits a range of medical applications

suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo stringent material specifications. However, several Trinseo

These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo

These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo

These resins were designed for automotive applications, These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting These resins were designed for automotive applications, suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting stringent material specifications. However, several Trinseo suiting both extrusion and injection moulding and meeting suiting both extrusion and injection moulding and meeting

(diabetes), hand-held monitoring and other home healthcare

Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.

devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.moulded applications in the home health device market.


devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection

(diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on Magnum 8391 MED, making it Trinseo’s offering for injection devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare devices. Therefore, Trinseo obtained biocompatibility on (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices such as housings for inhalers (asthma sprays), injection devices (diabetes), hand-held monitoring and other home healthcare such as housings for inhalers (asthma sprays), injection devices

moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection moulded applications in the home health device market.Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection Magnum 8391 MED, making it Trinseo’s offering for injection

In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels

with SAN to make an ABS resin for injection moulding. This

concentrate. Coagulation requires salts or acid to separate concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This with SAN to make an ABS resin for injection moulding. This

resin and the final product is more yellow. residuals. The compounding step adds thermal history to the resin and the final product is more yellow. resin and the final product is more yellow. resin and the final product is more yellow. resin and the final product is more yellow. residuals. The compounding step adds thermal history to the resin and the final product is more yellow. resin and the final product is more yellow. resin and the final product is more yellow.

8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour


MATERIALSMATERIALS

Material Assets

MATERIALS

polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded

In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS

method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the resin and the final product is more yellow.

with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the resin and the final product is more yellow.


method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the resin and the final product is more yellow.

with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant

concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This

concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the

Material Assetshree key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home

hree key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home

Material AssetsMaterial Assetshree key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home

healthcare. Material suppliers are adapting

In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the

In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS

the polymer from the water. This concentrate is compounded

in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS

for single-use devices, and the shift toward home healthcare. Material suppliers are adapting to support these market needs, developing

in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded the polymer from the water. This concentrate is compounded

polymer. The latex is then coagulated, producing an ABS

the polymer from the water. This concentrate is compounded

polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This with SAN to make an ABS resin for injection moulding. This

concentrate. Coagulation requires salts or acid to separate concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This with SAN to make an ABS resin for injection moulding. This

8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability /

Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in

8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour

moulding performance at different conditions; UV stability in comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in

resin and the final product is more yellow.

Trinseo conducted tests to identify the market fit of Magnum

residuals. The compounding step adds thermal history to the resin and the final product is more yellow.






Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour

polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate

residuals. The compounding step adds thermal history to the residuals. The compounding step adds thermal history to the

the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the

polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This

Material AssetsMaterial AssetsMaterial AssetsMaterial AssetsMaterial AssetsMaterial AssetsIn an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels

Material AssetsIn an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels in water through a batch process. This requires high levels In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate

residuals. The compounding step adds thermal history to the

in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS

method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the

concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the

in water through a batch process. This requires high levels in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded

Material AssetsMaterial AssetsMaterial AssetsIn an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS

method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the


aesthetic, performance and haptic requirements. Therefore, aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, medical requirements with the Magnum ABS resins, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, medical requirements with the Magnum ABS resins,

comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.indoor exposure and residual volatiles levels.


explains how the company is meeting


explains how the company is meeting

medical requirements medical requirements


company is meeting medical requirements

Ben Porter, Trinseo,


aesthetic, performance and haptic requirements. Therefore, demands materials that meet functional,

aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins,

aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins,


aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting

company is meeting medical requirements demand for home healthcare devices, medical requirements

with its resins

demand for home healthcare devices, company is meeting

medical requirements with its resinswith its resins

demand for home healthcare devices, for which OEMs require non-industrial, aesthetically-appealing equipment. This demands materials that meet functional,

aesthetic, performance and haptic requirements. Therefore,

medical requirements with its resins

demands materials that meet functional, aesthetic, performance and haptic requirements. Therefore, Trinseo’s TS&D team is showing its capabilities in meeting medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved

Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability /

medical requirements with the Magnum ABS resins, demonstrating the potential benefits for customers involved comparison, adding colour masterbatches; thermal stability /

moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.

8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in

pleasing. The latter trend is driven by demand for home healthcare devices,


Putting Magnum 8391 MED to the testPutting Magnum 8391 MED to the test

Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum

comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in

8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in


moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in


industry today are prevention of infection, demand for single-use devices, and the shift toward home industry today are prevention of infection, demand for single-use devices, and the shift toward home

hree key trends driving innovation in the medical device industry today are prevention of infection, demand hree key trends driving innovation in the medical device industry today are prevention of infection, demand hree key trends driving innovation in the medical device industry today are prevention of infection, demand for single-use devices, and the shift toward home Three key trends driving innovation in the medical device industry today are prevention of infection, demand

aesthetically-appealing equipment. This Putting Magnum 8391 MED to the test

aesthetically-appealing equipment. This

residuals. The compounding step adds thermal history to the resin and the final product is more yellow.

Putting Magnum 8391 MED to the testaesthetically-appealing equipment. This

pleasing. The latter trend is driven by demand for home healthcare devices, for which OEMs require non-industrial, aesthetically-appealing equipment. This


industry today are prevention of infection, demand




industry today are prevention of infection, demand

healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are

industry today are prevention of infection, demand for single-use devices, and the shift toward home




industry today are prevention of infection, demand for single-use devices, and the shift toward home

healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are

industry today are prevention of infection, demand hree key trends driving innovation in the medical device industry today are prevention of infection, demand industry today are prevention of infection, demand

healthcare. Material suppliers are adapting for single-use devices, and the shift toward home

healthcare. Material suppliers are adapting healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are chemically resistant plastics which are

healthcare. Material suppliers are adapting to support these market needs, developing healthcare. Material suppliers are adapting to support these market needs, developing healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices,

the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This robust to sterilisation and aesthetically the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This robust to sterilisation and aesthetically

pleasing. The latter trend is driven by demand for home healthcare devices,


comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.

comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.

8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.

8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.

8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.

8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability /





moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in indoor exposure and residual volatiles levels.




moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in




Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour


Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability /

Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in

Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability /

Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum

Tindustry today are prevention of infection, demand for single-use devices, and the shift toward home Tindustry today are prevention of infection, demand

healthcare. Material suppliers are adapting to support these market needs, developing chemically resistant plastics which are Ben Porter, Trinseo, chemically resistant plastics which are robust to sterilisation and aesthetically chemically resistant plastics which are robust to sterilisation and aesthetically chemically resistant plastics which are robust to sterilisation and aesthetically

aesthetically-appealing equipment. This for which OEMs require non-industrial,





Ben Porter, Trinseo, Ben Porter, Trinseo, explains how the

Ben Porter, Trinseo,

aesthetically-appealing equipment. This aesthetically-appealing equipment. This demands materials that meet functional,

aesthetic, performance and haptic requirements. Therefore, Putting Magnum 8391 MED to the test

for which OEMs require non-industrial, aesthetically-appealing equipment. This demands materials that meet functional,

for which OEMs require non-industrial,

chemically resistant plastics which are robust to sterilisation and aesthetically


company is meeting

to support these market needs, developing chemically resistant plastics which are robust to sterilisation and aesthetically

Ben Porter, Trinseo, robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices,

robust to sterilisation and aesthetically robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices,

company is meeting robust to sterilisation and aesthetically robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices, for which OEMs require non-industrial, aesthetically-appealing equipment. This

robust to sterilisation and aesthetically pleasing. The latter trend is driven by demand for home healthcare devices, for which OEMs require non-industrial, demand for home healthcare devices,


Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in



of emulsifiers (surfactants) to maintain a suspension of the of emulsifiers (surfactants) to maintain a suspension of the

a continuous process yields a resin with a highly consistent,

With emulsion ABS the end product has a yellower colour due


With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,


a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,

Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-

In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the

In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the

In an emulsion process the reaction of monomers occurs


of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS

method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant




of emulsifiers (surfactants) to maintain a suspension of the of emulsifiers (surfactants) to maintain a suspension of the of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS

In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs In an emulsion process the reaction of monomers occurs in water through a batch process. This requires high levels of emulsifiers (surfactants) to maintain a suspension of the polymer. The latex is then coagulated, producing an ABS

In an emulsion process the reaction of monomers occurs

with SAN to make an ABS resin for injection moulding. This

polymer. The latex is then coagulated, producing an ABS concentrate. Coagulation requires salts or acid to separate the polymer from the water. This concentrate is compounded with SAN to make an ABS resin for injection moulding. This




method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the residuals. The compounding step adds thermal history to the residuals. The compounding step adds thermal history to the

8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in

Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-

comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in moulding performance at different conditions; UV stability in

Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / comparison, adding colour masterbatches; thermal stability / 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour comparison, adding colour masterbatches; thermal stability / 8391 MED for medical applications, specifically: Base colour 8391 MED for medical applications, specifically: Base colour

residuals. The compounding step adds thermal history to the residuals. The compounding step adds thermal history to the


residuals. The compounding step adds thermal history to the

Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum

method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant with SAN to make an ABS resin for injection moulding. This method results in impurities including surfactant and coagulant method results in impurities including surfactant and coagulant residuals. The compounding step adds thermal history to the

Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum 8391 MED for medical applications, specifically: Base colour Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum Trinseo conducted tests to identify the market fit of Magnum





With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due With emulsion ABS the end product has a yellower colour due to higher polymer processing aid loading. ABS produced in to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, to higher polymer processing aid loading. ABS produced in a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,


a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,

Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-Magnum 8391 MED was compared with established, better-

a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent, a continuous process yields a resin with a highly consistent,

44 W W W . M E D I C A L P L A S T I C S N E W S . C O M

Here, colour data points are subdivided into three colour axes L, a and b, resulting in the final E value.

Colour comparisons were made based on three optical scenarios to capture different visible perceptions: Daylight; evening light with a higher yellow and red light fraction and artificial light representing a shopping environment.

Since Magnum 8391 MED offers a whiter colour than emulsion ABS, a colour masterbatch was added: a pure TiO2-based colour masterbatch with approximately 50% pigment loading, as the predominant colour in medical is white.

Figure 4 shows a first comparison divided into L, a and b values for a ‘medium-coloured’ ABS with 3% of masterbatch loading. Both grades show sufficient colour saturation which explains little difference on L values. The a values (“red/green”) are very close, too. The main difference is visible on b values, determining the yellow to blue differences. The emulsion ABS has a higher b value, relating to a more yellow color. This value has the most impact on the resulting ΔE value.

Figure 4: Competitive resin performance versus Magnum 8391 MED (with 3% white Masterbatch)

This observation is enforced when looking at a fairly ‘overloaded’ emulsion ABS with a 3% Magnum 8391 MED loading. Still, a higher Δb remains for the Emulsion ABS. So even with more than double the colour pigments loaded, this emulsion ABS can’t deliver the same white colour as Magnum 8391 MED, underlining the potential cost savings due to less use of colour masterbatches for white colours.

Figure 5: Competitive resin with 6.25% MB 744 versus 8391 Magnum MED

TEST TWO: THERMAL STABILITYTrinseo also measured differences in discoloration at molding temperatures of 220§C versus 300§C for both ABS types. The results show an average discoloration ΔE of 0.98 for MAGNUM ABS whereas the discoloration of emulsion ABS was around 1.25. This test shows that MAGNUM offers improved thermal stability. This translates to a more robust and stable converting process with a wide processing window. Emulsion ABS showed a higher discoloration of over 25%.

Figure 6: Thermal stability of MAGNUM ABS resins versus competitive resins in Daylight (D65), Evening light (A10) and Artificial light (F11)

TEST THREE: UV STABILITY As most hospital or home healthcare devices are designed for indoor use behind windows, a UV stability study was done. QUV-A represents a typical indoor exposure and was selected for this purpose: MAGNUM§ 8391 MED and incumbent emulsion ABS resins were exposed in the UV-2000 tester according to the following ASTM G154 conditions: U.V.-A 340 nm lamps; eight hrs UV at 60§C black panel temperature; four hours condensation at 50§C black panel temperature; E = 0.77W/m§

As mass and emulsion ABS offer different starting points regarding colour (yellowing level), the 3% white masterbatch (approx. 50% TiO2 pigment loading) was selected for UV investigations to put both materials at a comparable colour level.

Colour measurements were taken after 24, 48, 72 and 100 hour exposures. Due to less impurity in the final product, Magnum 8391 MED remains more colour stable over time.

Figure 7: Results for QUV-A (with 3% Masterbatch 744)

0

5

10

15

0 50 100

∆E

$me [hours]

QUV-‐A

compe**ve resin (Emulsion ABS + 3% MB 744 (white) Magnum 8391 + 3% MB 744 (white)

MATERIALS

222 dLdbdadE ++=

46 W W W . M E D I C A L P L A S T I C S N E W S . C O M

TEST FOUR: VOLATILESMany healthcare device providers want to minimise the migrating volatiles in materials for their devices. Regarding thermoplastics, the fraction of residual monomers, di- and trimeres are potentially relevant, as they are fairly volatile.

To determine the level of volatiles, a gas chromatography (GC) and high performance liquid chromatography (HPLC) are used. The cleaner manufacturing process helps Magnum 8391 MED to have a smaller volatile profile than competitive emulsion ABS.

Conclusion

Trinseo tests show clear advantages of using Magnum Mass ABS technology in the medical industry. A more compact product regarding volatiles, along with its purer base colour make Magnum 8391 MED suitable for medical device manufacturers. Magnum produced in a continuous mass ABS process results in a resin with a highly consistent, white base colour, making it suitable for easy and consistent self-colouring.

Self-colouring can be cost competitive and offers other benefits to OEMs and molders, letting a manufacturer buy a polymer resin and add colour masterbatch at the injection molding machine stage, instead of buying different compounded grades, which is costly. Trinseo can also offer pre-coloured options..

The superior natural base colour of Magnum resins is very attractive. Studies show high potential cost savings of around 50% for light colours due to less colour masterbatch usage.

Compared with emulsion, Magnum‘s beneficial UV stability means parts last longer, taking longer to discolour. The high purity and low residual volatiles offer benefits for medical applications. In summary, Magnum ABS resin offers a more stable and robust solution for converters and is a good market fit for medical applications, affording technical and economic benefits.

0

5

10

15

0 50 100

∆E

$me [hours]

QUV-‐A

compe**ve resin (Emulsion ABS + 3% MB 744 (white) Magnum 8391 + 3% MB 744 (white)

0 0.2 0.4 0.6 0.8 1

1.2 1.4 1.6

compe&&ve resin Magnum 8391 MED

vola&les [%]

Vola&le sec&on, determined by GC and HPLC Figure 8: Percent Volatiles of emulsion versus mass ABS

Figure 9: Lot-to-lot Consistency of ABS Resins versus Competitive Resins

MATERIALS

47W W W . M E D I C A L P L A S T I C S N E W S . C O M

Material Assets Material AssetsMaterial Assets … · ABS, a colour masterbatch was added: a pure...

Documents

Transcript of Material Assets Material AssetsMaterial Assets … · ABS, a colour masterbatch was added: a pure...